In this cellular context, NF-κB suppresses miR-140 expression, resulting in the upregulation of DNMT1 and increased NF-κB activity, forming a positive feedback loop that promotes liver cancer [135,136]. This evidence concerns the gene NFKB1 and liver cancer.